[1] Cummings SR, Rubin SM, Black D. The future of hip fractures in the united states. Numbers, costs, and potential effects of postmenopausal estrogen [J]. Clin Orthop Relat Res, 1990, (252):163-166.
[2] Murphy DK, Randell T, Brennan KL, et al. Treatment and displacement affect the reoperation rate for femoral neck fracture [J]. Clin Orthop Relat Res, 2013,471(8):2691-2702.
[3] Lawrence VA, Hilsenbeck SG, Noveck H, et al. Medical complications and outcomes after hip fracture repair [J]. Arch Intern Ned, 2002,162(18):2053-2057.
[4] 李绍光. 老年髋部骨折后过高死亡风险分析与应用cox-2抑制剂抗炎治疗改善预后的临床观察[D]. 中国人民解放军医学院, 2013.
[5] Foss NB, Palm H, Krasheninnikoff M, et al. Impact of surgical complications on length of stay after hip fracture surgery [J]. Injury, 2007,38(7):780-784.
[6] Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress t-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli [J]. Blood, 2002, 99(10):3838-3843.
[7] Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate b-cell functions [J]. Blood, 2006,107(1):367-372.
[8] Perl M, Gebhard F, Knoferl MW, et al. The pattern of preformed cytokines in tissues frequently affected by blunt trauma [J]. Shock, 2003,19(4):299-304.
[9] Tyburski JG, Dente C, Wilson RF, et al. Differences in arterial and mixed venous il-6 levels: The lungs as a source of cytokine storm in sepsis [J]. Surgery, 2001, 130(4):748-752.
[10] Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis [J]. Science, 1997, 275(5302): 964-967.
[11]Brazelton TR, Rossi FM, Keshet GI, et al. From marrow to brain: Expression of neuronal phenotypes in adult mice [J]. Science, 2000, 290(5497):1775-1779.
[12]Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell [J]. Cell, 2001,105(3):369-377.
[13]Nasef A, Mazurier C, Bouchet S, et al. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression [J]. Cell Immunol, 2008, 253(1-2):16-22.
[14]Rafei M, Hsieh J, Fortier S, et al. Mesenchymal stromal cell-derived ccl2 suppresses plasma cell immunoglobulin production via stat3 inactivation and pax5 induction [J]. Blood, 2008, 112(13):4991-4998.
[15]Lepelletier Y, Lecourt S, Renand A, et al. Galectin-1 and semaphorin-3a are two soluble factors conferring t-cell immunosuppression to bone marrow mesenchymal stem cell [J]. Stem Cells Dev, 2010,19(7):1075-1079.
[16]Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin e(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production [J]. Nat Med, 2009,15(1):42-49.
[17]Ouyang W, Rutz S, Crellin NK, et al. Regulation and functions of the il-10 family of cytokines in inflammation and disease [J]. Ann Rev Immunol, 2011,29: 71-109. |